The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
and asthma," the CMS fact sheet states. In addition to Ozempic and Wegovy, other prescription medications selected for negotiations include Calquence, Trelegy Ellipta, Rybelsus, Linzess and Otezla.
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
Among the 10 drugs listed, Medicare Part D spent the most on Ozempic, Rybelsus and Wegovy, at $14.43 billion, according to a CMS fact sheet on Friday. Nearly 2.3 million enrollees used those drugs ...